Research Study

The Multidisciplinary, Multimodality, But Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Trial
Principal Investigator 
David Wood

Overview

Body Locations and Systems 
Heart
ClinicalTrials.gov# 
NCT02287662
Status 
Closed to Recruitment
Study Start/End 
Jan 1, 2015 to Dec 29, 2017
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Naomi Uchida, Research Coordinator
Phone 
604-875-4521
Purpose of Study 

The primary objective of this trial is to provide a rigorous assessment of the efficacy, feasibility and safety of the Vancouver 3M Clinical Pathway protocol in patients undergoing elective transfemoral TAVR with the SAPIEN XT valve.


 

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.